Top

Published in:

01-10-2010 | Original Article

Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors

Authors: Stefan Hinz, Ahmed Magheli, Steffen Weikert, Wolfgang Schulze, Hans Krause, Mark Schrader, Kurt Miller, Carsten Kempkensteffen

Published in: World Journal of Urology | Issue 5/2010

Abstract

Introduction

Enhancer of Zeste 2 (EZH2) is an epigenetic transcriptional repressor involved in cell cycle control and cell fate decisions. Since these processes play key roles during intact spermatogenesis, deregulation of EZH2 expression may contribute to the development and progression of benign and malignant testicular diseases. The objective of this study was to investigate the expression profile of EZH2 in testicular germ cell tumors (TGCT) and spermatogenic defects.

Material and methods

Real-time RT-PCR was applied to quantify the m-RNA expression of EZH2 in 64 seminomas 36 non-seminomas, 4 carcinomas in situ (CIS), 40 samples harboring impaired spermatogenesis and 24 normal testicular reference biopsies.

Results

EZH2 was expressed in 99% of TGCT samples and in all biopsies with intact spermatogenesis. Its expression levels were highest in normal testicular tissue, and continuously decreased with malignant transformation to CIS and further progression to invasive TGCT (P < 0.001). EZH2 tumor levels were not related to the histological TGCT subtype or clinical tumor stage. Comparison of distinct stages of spermatogenic failure revealed an inverse association of EZH2 levels to the severity of the spermatogenic defect (P < 0.001).

Conclusion

Our data strongly suggest that in TGCT EZH2 does not exert its often assumed oncogenic properties during malignant transformation and progression. High EZH2 levels in normal testicular tissue and the inverse association of its expression levels with the severity of spermatogenic failure point to its potential value as a molecular marker for spermatogenic defects and may indicate an important physiological role of EZH2 during intact spermatogenesis.

Chaganti RS, Houldsworth J (2000) Genetics and biology of adult human male germ cell tumors. Cancer Res 60(6):1475–1482PubMed

Biermann K, Steger K (2007) Epigenetics in male germ cells. J Androl 28(4):466–480CrossRefPubMed

Jacobs JJ, Van LM (2002) Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta 1602(2):151–161PubMed

Orlando V (2003) Polycomb, epigenomes, and control of cell identity. Cell 112(5):599–606CrossRefPubMed

Lee TI, Jenner RG, Boyer LA et al (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125(2):301–313CrossRefPubMed

Sasaki M, Yamaguchi J, Itatsu K et al (2008) Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol 215(2):175–183CrossRefPubMed

Tonini T, D’Andrilli G, Fucito A et al (2008) Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements. J Cell Physiol 214(2):295–300CrossRefPubMed

Varambally S, Dhanasekaran SM, Zhou M et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419(6907):624–629CrossRefPubMed

Bachmann IM, Halvorsen OJ, Collett K et al (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24(2):268–273CrossRefPubMed

10.

Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647(1–2):21–29PubMed

11.

Gunster MJ, Raaphorst FM, Hamer KM et al (2001) Differential expression of human Polycomb group proteins in various tissues and cell types. J Cell Biochem 81(S36):129–143CrossRef

12.

Jezek D, Knuth UA, Schulze W (1998) Successful testicular sperm extraction (TESE) in spite of high serum follicle stimulating hormone and azoospermia: correlation between testicular morphology, TESE results, semen analysis and serum hormone values in 103 infertile men. Hum Reprod 13(5):1230–1234CrossRefPubMed

13.

Schulze W, Thoms F, Knuth UA (1999) Testicular sperm extraction: comprehensive analysis with simultaneously performed histology in 1418 biopsies from 766 subfertile men. Hum Reprod 14(Suppl 1):82–96PubMed

14.

Bracken AP, Pasini D, Capra M et al (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22(20):5323–5335CrossRefPubMed

15.

Zeidler M, Varambally S, Cao Q et al (2005) The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neoplasia 7(11):1011–1019CrossRefPubMed

16.

Hinz S, Kempkensteffen C, Christoph F et al (2008) Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder. J Cancer Res Clin Oncol 134(3):331–336CrossRefPubMed

17.

Weikert S, Schrader M, Christoph F et al (2005) Quantification of survivin mRNA in testes of infertile patients and in testicular germ cell tumours: high levels of expression associated with normal spermatogenesis. Int J Androl 28(4):224–229CrossRefPubMed

18.

Feig C, Kirchhoff C, Ivell R et al (2007) A new paradigm for profiling testicular gene expression during normal and disturbed human spermatogenesis. Mol Hum Reprod 13(1):33–43CrossRefPubMed

19.

Weikert S, Schrader M, Muller M et al (2004) Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patients. Int J Androl 27(3):161–165CrossRefPubMed

20.

Lee ER, Murdoch FE, Fritsch MK (2007) High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Stem Cells 25(9):2191–2199CrossRefPubMed

21.

Raaphorst FM, Otte AP, van Kemenade FJ et al (2001) Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation. J Immunol 166(10):5925–5934PubMed

Title: Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors
Authors: Stefan Hinz
Ahmed Magheli
Steffen Weikert
Wolfgang Schulze
Hans Krause
Mark Schrader
Kurt Miller
Carsten Kempkensteffen
Publication date: 01-10-2010
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 5/2010
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-009-0498-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors

Abstract

Introduction

Material and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Material and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2010

Shock wave induces chronic renal lesion through activation of the nuclear factor kappa B signaling pathway

Photodynamic therapy for focal ablation of the prostate

Laparoscopic dismembered pyeloplasty: technique and results in 105 patients

To clamp or not to clamp? Bladder management by suprapubic catheterization in patients with neurogenic bladder dysfunction

Erratum to: Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence

Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy